BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 913969)

  • 1. Cancer in colitis: assessment of the individual risk by clinical and histological criteria.
    Lennard-Jones JE; Morson BC; Ritchie JK; Shove DC; Williams CB
    Gastroenterology; 1977 Dec; 73(6):1280-9. PubMed ID: 913969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
    Löfberg R
    Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant potential of chronic ulcerative colitis. Preliminary report.
    Nugent FW; Haggit RC; Colcher H; Kutteruf GC
    Gastroenterology; 1979 Jan; 76(1):1-5. PubMed ID: 758130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma and epithelial dysplasia complicating ulcerative colitis.
    Cook MG; Goligher JC
    Gastroenterology; 1975 May; 68(5 Pt 1):1127-36. PubMed ID: 1126593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
    Markowitz J; McKinley M; Kahn E; Stiel L; Rosa J; Grancher K; Daum F
    Am J Gastroenterol; 1997 Nov; 92(11):2001-6. PubMed ID: 9362180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric DNA analysis of ulcerative colitis using paraffin-embedded biopsy specimens: comparison with morphology and DNA analysis of fresh samples.
    Hartmann DP; Montgomery EA; Carr NJ; Gupta PK; Azumi N
    Am J Gastroenterol; 1995 Apr; 90(4):590-6. PubMed ID: 7717317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of dysplasia in the columnar cuff after stapled restorative proctocolectomy.
    Coull DB; Lee FD; Henderson AP; Anderson JH; McKee RF; Finlay IG
    Br J Surg; 2003 Jan; 90(1):72-5. PubMed ID: 12520578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's colitis: the incidence of dysplasia and adenocarcinoma in surgical patients.
    Maykel JA; Hagerman G; Mellgren AF; Li SY; Alavi K; Baxter NN; Madoff RD
    Dis Colon Rectum; 2006 Jul; 49(7):950-7. PubMed ID: 16729218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplasia and cancer in ulcerative colitis: a soluble problem?
    Riddell RH
    Scand J Gastroenterol Suppl; 1984; 104():137-49. PubMed ID: 6597546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of dysplasia and cancer in the ileal pouch mucosa after restorative proctocolectomy for ulcerative proctocolitis is low: a long-term term follow-up study.
    Börjesson L; Willén R; Haboubi N; Duff SE; Hultén L
    Colorectal Dis; 2004 Nov; 6(6):494-8. PubMed ID: 15521942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulcerative colitis in Stockholm County--a study of epidemiology, prognosis, mortality and cancer risk with special reference to a surveillance program.
    Broström O
    Acta Chir Scand Suppl; 1986; 534():1-60. PubMed ID: 3472421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic surveillance for cancer in chronic ulcerative colitis.
    Fuson JA; Farmer RG; Hawk A; Sullivan BH
    Am J Gastroenterol; 1980 Feb; 73(2):120-6. PubMed ID: 7395838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer in universal and left-sided ulcerative colitis: factors determining risk.
    Greenstein AJ; Sachar DB; Smith H; Pucillo A; Papatestas AE; Kreel I; Geller SA; Janowitz HD; Aufses AH
    Gastroenterology; 1979 Aug; 77(2):290-4. PubMed ID: 447042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of cancer surveillance in ulcerative colitis.
    Suzuki K; Muto T; Shinozaki M; Higuchi Y; Sawada T; Saito Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():40-2. PubMed ID: 8563886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease (ulcerative colitis).
    Alpers D; Avioli LV
    Arch Intern Med; 1978 Feb; 138(2):286-91. PubMed ID: 626556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of dysplasia in ulcerative colitis.
    Vatn MH; Elgjo K; Bergan A
    Scand J Gastroenterol; 1984 Oct; 19(7):893-5. PubMed ID: 6531658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.